Loading...
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Bicyclic nitroimidazoles, including PA-824, are exciting candidates for the treatment of tuberculosis. These prodrugs require intracellular activation for their biological function. We found that Rv3547 is a deazaflavin-dependent nitroreductase (Ddn) that converts PA-824 into three primary metabolit...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2723733/ https://ncbi.nlm.nih.gov/pubmed/19039139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.1164571 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|